The latter is particularly relevant in populations with abdominal obesity, as lower muscle efficiency and greater intramuscular fat infiltration increase metabolic dysfunction and inflammation [89,90], altering myokine secretion and exacerbating insulin resistance and cardiometabolic risk [91,92]. This evidence concerns the gene INS and Abdominal obesity.